Current status of clinical trials about thoracic surgery in lung cancer

Abstract

The incidence of lung cancer in China ranks first and second among men and women respectively. Meanwhile, lung cancer is also the leading cause of death in malignant tumors in China. Surgical treatment is of great significance in improving the prognosis of patients with lung cancer, and the number of related clinical trials is increasing year by year. Through a retrospective review of clinical trials in the field of lung cancer and thoracic surgery on the Clinicaltrials.gov platform, this article finds that relevant clinical trials focus on treatment, perioperative management and basic research. Although the clinical trials in China started late, they have developed rapidly and the number of clinical trials ranked second. In addition, there are some shortcomings in the clinical trials of China in terms of trial design and research scope, and there is still a gap between Chinese and foreign trials.